News - Leukogene

Leukogene Therapeutics welcomes industry veteran and leader Dr. Sandeep Gupta as its Chief Executive Officer

2 weeks ago

CHARLESTON, S.C.–(BUSINESS WIRE)–Leukogene Therapeutics Inc., a biotech company with the mission to deliver innovative immunotherapies for hard-to-treat cancers and emphasis on immunologically “cold” tumors, announced today the appointment of Dr.…

Dr. Nathan Dolloff of MUSC and Leukogene Therapeutics Inc. awarded SCRA grant for development of MHC class II targeted cancer immunotherapy

News

6 months ago

SCRA awarded the Medical University of South Carolina $870,000. MUSC has $397,000 in matching funds for a total of over one million dollars to bring three innovations into the marketplace.…